Trial Profile
A phase II, multicenter, open-labeled study of immunotherapy with autologous dexosomes for patients with stage IV melanoma
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Melanoma vaccine (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 13 Oct 2005 New trial record.